Your Blood Work Is "Normal" But Are You Optimized? Here's the Difference
The reference ranges on your lab report were designed to catch disease — not to help you avoid it for another 40 years.
You go for your annual physical. The doctor orders blood work. The results come back, and everything is flagged green. “Normal.” You leave feeling reassured, maybe even a little smug. Good news, right?
Maybe not. The word “normal” on a lab report is doing a lot less work than you think. It does not mean healthy, it does not mean optimal, and it definitely does not mean you are aging well at the cellular level. It means, roughly, that you are not in the bottom or top 2.5% of the people tested at that lab. That is a much lower bar than it sounds — and in some cases, it is the wrong bar entirely.
This matters enormously if you care about how you age. Standard blood panels were designed by clinicians, for clinicians, to flag acute disease. That’s a useful goal. But longevity medicine asks a different question: not “is this person sick?” but “is this person on a trajectory to get sick in 10, 20, or 30 years?” Those questions require different numbers, different markers, and a fundamentally different way of reading results.
Here is what the gap actually looks like, and what to do about it.
The statistical trick hiding inside every lab report
Before you can understand why “normal” is often insufficient, you need to understand how reference ranges are built. It is not complicated, but it is probably not what you assumed. 🔬
According to guidelines from the International Federation of Clinical Chemistry and Laboratory Medicine, reference intervals are set as the central 95% of values from a reference population. The top and bottom 2.5% are excluded, and everything in the middle becomes “normal.” That sounds reasonable until you think about it for a moment.
First, the reference population is not necessarily healthy people. As Dr. James Staheli, D.O., a hormone specialist, puts it plainly: “Normal in this context often means common, not optimal.” In practice, reference ranges are derived from whoever gets tested at that lab. In a country where roughly 60% of adults have some degree of metabolic dysfunction, the people establishing your “normal” fasting insulin range include a significant number of people who are already insulin resistant. The upper boundary of normal drifts upward to accommodate the unhealthy majority.
Second, the math creates its own problem. If you run a panel with 10 blood tests, and each test has a 95% chance of reading “normal” in a healthy person, the probability that all 10 come back normal is only around 60%. In other words: the more tests you run, the more likely you are to get a false flag — or to miss a real one that falls just inside the boundary.
Third, and most consequentially for longevity, the reference range tells you nothing about where within normal your result sits in relation to long-term disease risk. A fasting glucose of 98 mg/dL is technically normal. It is also well above the optimal zone for slow aging, as research published by the longevity medicine team at SuperAge identifies the longevity-optimal fasting glucose window as 70 to 85 mg/dL. Your doctor will tell you 98 is fine. A longevity physician will tell you it is worth addressing. 📊
Longevity-focused integrative physician Dr. Candice Knight, M.D., M.P.H., makes the distinction sharply: “A ‘normal’ result tells us you’re not in crisis, but this broad middle ground can still hide significant dysfunction before disease shows up.” That dysfunction, left unaddressed for years, is where chronic disease actually comes from.
The markers where “normal” most often misleads
Some blood markers are more treacherous than others when it comes to this gap. A few are worth understanding specifically. 💊
Fasting insulin is probably the single most dramatic example. The standard lab reference range runs from roughly 2 to 25 µIU/mL — sometimes as high as 24.9 µIU/mL at major labs like LabCorp. A result of 20 µIU/mL will appear perfectly normal on your report. Functional and precision medicine practitioners consider anything above 8 to 10 µIU/mL to indicate meaningful insulin resistance, and the optimal longevity target is closer to 2 to 5 µIU/mL.
This matters because fasting insulin is the earliest detectable marker of metabolic dysfunction, often appearing 10 to 20 years before blood glucose or HbA1c rise into abnormal territory. By the time your glucose looks bad, insulin resistance has already been driving upstream damage — to your arteries, your liver, your brain — for a long time. Most doctors do not even order fasting insulin as a routine test.
ApoB versus LDL cholesterol is the cardiovascular equivalent. Standard lipid panels measure LDL cholesterol concentration. Peter Attia, a physician and longevity researcher who wrote Outlive, argues consistently that this is the wrong number — and the evidence backs him. What actually drives plaque formation is the number of atherogenic particles circulating in the blood, which ApoB measures directly. Two people with identical LDL cholesterol can have very different ApoB levels, and it is ApoB that predicts risk. Attia targets ApoB below 60 mg/dL — roughly the 5th percentile of the adult population. Standard labs flag concern only above 100 mg/dL or so. That gap is not a rounding error; it represents decades of cardiovascular risk quietly accumulating.
Hs-CRP, the high-sensitivity version of the C-reactive protein inflammation marker, is another one. Standard labs consider anything under 3 mg/L acceptable. Prevention clinics use categories of low risk (under 1.0 mg/L), intermediate (1.0 to 3.0 mg/L), and high above that. But a 2017 meta-analysis of 83,995 subjects confirmed that all-cause mortality and cardiovascular mortality both begin rising meaningfully at 1 mg/L or above — meaning the “normal” upper boundary is already in the risk zone. The longevity-optimal target is under 0.5 mg/L.
HbA1c, the three-month average of blood sugar control, tells a similar story. The diabetic threshold sits at 6.5%. Prediabetes begins at 6.0%. But centenarian studies consistently show HbA1c below 5.5% throughout long lives, and optimal longevity range is considered 4.8 to 5.2% by most precision medicine practitioners. A result of 5.8% looks “slightly elevated” to your GP but has already been in prediabetic territory for years by the time the label arrives. 🩸
Homocysteine rounds out the list of markers routinely ignored at standard levels that longevity medicine takes seriously. Elevated homocysteine is directly toxic to the endothelial lining of blood vessels, independently associated with cardiovascular disease and stroke, and one of the most consistent findings in the epidemiology of dementia — roughly doubling Alzheimer’s risk in multiple large studies. The good news: it is highly modifiable with B vitamins. The frustrating news: your doctor probably did not order it.
What longevity-focused blood work actually looks at
So what does an optimized panel include beyond the basics? 🧬
Peter Attia’s five most critical markers, as outlined in Outlive and across his medical practice, are:
ApoB (atherogenic particle count, superior to LDL-C for cardiovascular risk)
Lp(a) (genetically determined cardiovascular risk, checked once is usually sufficient)
HbA1c (metabolic health, target under 5.5% ideally approaching 5.1%)
Fasting insulin (earliest insulin resistance marker, target 2–5 µIU/mL)
OGTT with insulin (oral glucose tolerance test, catching post-meal glucose dysfunction)
Beyond Attia’s core five, a 2025 consensus of 60 international aging researchers identified 14 key biomarkers of aging, many of them inexpensive blood tests. The longevity-relevant additions most worth knowing include:
Hs-CRP (chronic inflammation, target under 0.5 mg/L)
Homocysteine (endothelial and brain health, optimal under 7 µmol/L)
Vitamin D (25-OH) (immune function, bone health, inflammation — optimal 40 to 60 ng/mL; many people’s “normal” 20 ng/mL is actually deficient by functional standards)
Ferritin (iron storage, also an inflammation marker — excess ferritin above 150–200 ng/mL in men may signal oxidative stress)
If you are curious about which of these tests you can actually order yourself, we have covered the most accessible options in detail in our 7 longevity lab tests you can order today piece.
Have you ever looked at a lab result flagged “normal” and wondered if that number actually told you anything useful? You are not alone — this is one of the most common frustrations people bring to longevity-focused physicians.
What to do with this information
Understanding the gap between normal and optimal is useful. Knowing how to act on it is better. A few practical steps: 🚀
Request the markers your doctor is not ordering. Fasting insulin is rarely included in standard panels. ApoB may not be. Hs-CRP might be skipped unless you ask. Most labs will run these if ordered — they are not exotic or expensive. In the U.S., many can be accessed through direct-to-consumer labs without a doctor’s order.
Bring your own target ranges to the conversation. If your doctor says your fasting insulin of 18 is “normal,” you can respectfully ask where it falls within the functional medicine optimal range of 2 to 5. You are not challenging their competence; you are asking a more specific question than the lab report answers. Most good physicians appreciate the initiative.
Think in trends, not snapshots. A single fasting glucose of 92 tells you less than a trend of 84, 88, 92 over three years. That upward trajectory is a signal even if none of the individual values triggered a flag. Testing consistently, every 6 to 12 months for metabolic markers, gives you the trend line.
Understand that context changes interpretation. A meta-analysis finding elevated all-cause mortality risk at higher fasting insulin levels controlled for age, sex, and BMI — but your individual results still need to be read against your personal history, medications, and lifestyle. The numbers on this page are starting points for a conversation, not a self-diagnosis protocol.
We have gone deeper on the biomarkers most worth tracking after 40 in our 5 blood test biomarkers everyone over 40 should follow piece — worth reading alongside this one.
The broader point is this: standard medicine is built to catch you when you fall. Longevity medicine is built to keep you from falling. Those are different tools for a different goal, and the blood work that supports the second goal is mostly available to you right now, if you know to ask for it. The American Heart Association’s position on ApoB testing has shifted meaningfully in recent years, and the NIH’s work on insulin resistance early detection is publicly accessible and worth understanding.
So: when was the last time someone checked your fasting insulin? And do you actually know what the number was?